Search Page

1

Cite

Share

Bevacizumab: overview of the literature.

Braghiroli MI, Sabbaga J, Hoff PM. Braghiroli MI, et al. Among authors: sabbaga j. Expert Rev Anticancer Ther. 2012 May;12(5):567-80. doi: 10.1586/era.12.13. Expert Rev Anticancer Ther. 2012. PMID: 22594892 Review.

Cite

Share

2

Cite

Share

Integration of anti-vascular endothelial growth factor therapies with cytotoxic chemotherapy in the treatment of colorectal cancer.

Oliveira SC, Machado KK, Sabbaga J, Hoff PM. Oliveira SC, et al. Among authors: sabbaga j. Cancer J. 2010 May-Jun;16(3):220-5. doi: 10.1097/PPO.0b013e3181ddc7c4. Cancer J. 2010. PMID: 20526100 Review.

Cite

Share

3

Cite

Share

ERCC1 in advanced biliary tract cancer patients treated with chemotherapy: prognostic and predictive roles.

da Costa Miranda V, Braghiroli MI, Faria LD, Siqueira SA, Sabbaga J, Hoff PM, Riechelmann RP. da Costa Miranda V, et al. Among authors: sabbaga j. J Gastrointest Cancer. 2014 Mar;45(1):80-6. doi: 10.1007/s12029-013-9568-5. J Gastrointest Cancer. 2014. PMID: 24326865

Cite

Share

4

Cite

Share

Acute acalculous cholecystitis in a patient with metastatic renal cell carcinoma treated with sunitinib.

da Fonseca LG, Barroso-Sousa R, Sabbaga J, Hoff PM. da Fonseca LG, et al. Among authors: sabbaga j. Clin Pract. 2014 Apr 30;4(1):635. doi: 10.4081/cp.2014.635. eCollection 2014 Mar 27. Clin Pract. 2014. PMID: 24847435 Free PMC article.

Cite

Share

5

Cite

Share

The effects of palliative chemotherapy in metastatic colorectal cancer patients with an ECOG performance status of 3 and 4.

Crosara Teixeira M, Marques DF, Ferrari AC, Alves MF, Alex AK, Sabbaga J, Hoff PM, Riechelmann RP. Crosara Teixeira M, et al. Among authors: sabbaga j. Clin Colorectal Cancer. 2015 Mar;14(1):52-7. doi: 10.1016/j.clcc.2014.09.010. Epub 2014 Oct 18. Clin Colorectal Cancer. 2015. PMID: 25442812

Cite

Share

6

Cite

Share

A phase II trial with anti-Lewis-Y monoclonal antibody (hu3S193) for the treatment of platinum resistant/refractory ovarian, fallopian tube and primary peritoneal carcinoma.

Smaletz O, Diz MD, do Carmo CC, Sabbaga J, Cunha-Junior GF, Azevedo SJ, Maluf FC, Barrios CH, Costa RL, Fontana AG, Madrigal V, Wainstein AJ, Yeda FP, Alves VA, Moro AM, Blasbalg R, Scott AM, Hoffman EW. Smaletz O, et al. Among authors: sabbaga j. Gynecol Oncol. 2015 Aug;138(2):272-7. doi: 10.1016/j.ygyno.2015.05.023. Epub 2015 May 27. Gynecol Oncol. 2015. PMID: 26026738 Clinical Trial.

Cite

Share

7

Cite

Share

Comprehensive cancer-gene panels can be used to estimate mutational load and predict clinical benefit to PD-1 blockade in clinical practice.

Campesato LF, Barroso-Sousa R, Jimenez L, Correa BR, Sabbaga J, Hoff PM, Reis LF, Galante PA, Camargo AA. Campesato LF, et al. Among authors: sabbaga j. Oncotarget. 2015 Oct 27;6(33):34221-7. doi: 10.18632/oncotarget.5950. Oncotarget. 2015. PMID: 26439694 Free PMC article.

Cite

Share

8

Cite

Share

Phase 2 Trial of Metformin Combined With 5-Fluorouracil in Patients With Refractory Metastatic Colorectal Cancer.

Miranda VC, Braghiroli MI, Faria LD, Bariani G, Alex A, Bezerra Neto JE, Capareli FC, Sabbaga J, Lobo Dos Santos JF, Hoff PM, Riechelmann RP. Miranda VC, et al. Among authors: sabbaga j. Clin Colorectal Cancer. 2016 Dec;15(4):321-328.e1. doi: 10.1016/j.clcc.2016.04.011. Epub 2016 May 7. Clin Colorectal Cancer. 2016. PMID: 27262895 Clinical Trial.

Cite

Share

9

Cite

Share

Safety and Efficacy of a Modified FLOX Adjuvant Regimen for Patients With Stage III Colorectal Cancer Treated in the Community.

Protásio BM, Matutino A, Lage LV, Santana I, Ramos R, Sabbaga J, Capareli F, Saragiotto D, Riechelmann R, Hoff PM. Protásio BM, et al. Among authors: sabbaga j. Clin Colorectal Cancer. 2017 Mar;16(1):65-72. doi: 10.1016/j.clcc.2016.07.001. Epub 2016 Jul 19. Clin Colorectal Cancer. 2017. PMID: 27515842

Cite

Share

10

Cite

Share

Safety and efficacy of cytotoxic chemotherapy in hepatocellular carcinoma after first-line treatment with sorafenib.

da Fonseca LG, Marta GN, Braghiroli MIFM, Chagas AL, Carrilho FJ, Hoff PM, Sabbaga J. da Fonseca LG, et al. Among authors: sabbaga j. BMC Cancer. 2018 Dec 13;18(1):1250. doi: 10.1186/s12885-018-5173-0. BMC Cancer. 2018. PMID: 30545331 Free PMC article.

Cite

Share